< Back to previous page
Researcher
Simon De Meyer
- Disciplines:Laboratory medicine, Palliative care and end-of-life care, Regenerative medicine, Other basic sciences, Other health sciences, Nursing, Other paramedical sciences, Other translational sciences, Other medical and health sciences
Affiliations
- Cardiovascular Sciences, Kulak Kortrijk Campus (Department)
Responsible
From1 Aug 2015 → Today - Cardiovascular Sciences, Kulak Kortrijk Campus (Department)
Member
From1 Jan 2013 → Today - Biomedical Sciences Group, Kulak Kortrijk Campus (Section)
Member
From1 Oct 2012 → 31 Dec 2012 - Chemistry, Kulak Kortrijk Campus (Department)
Member
From1 Oct 2010 → 30 Sep 2012 - Faculty of Science, Kulak Kortrijk Campus (Faculty)
Member
From1 Oct 2001 → 30 Sep 2010
Projects
1 - 10 of 43
- Universal Chimeric Antigen Receptor (UniCAR) T-cell therapy: an innovative treatment for autoimmune diseaseFrom5 Apr 2023 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Universal chimeric antigen receptor (uniCAR)-T cell therapy to treat autoimmune diseases: immune mediated thrombotic thrombocytopenic purpura as a model system.From1 Mar 2023 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Endothelium-targeted gene therapy for von Willebrand disease using a hybrid adeno-transposon strategyFrom1 Jan 2023 → TodayFunding: FWO research project (including WEAVE projects)
- Flow cytometer for the Interdisciplinary Research Facility Life Sciences at Campus Kulak KortrijkFrom1 Jan 2023 → TodayFunding: BOF - scientific equipment program
- Towards improved thrombolysis in acute ischemic strokeFrom1 Jan 2021 → 31 Oct 2021Funding: BOF - postdoctoral mandates
- Light sheet microscopy for interdisciplinary research in life sciencesFrom1 Jan 2021 → 31 Dec 2022Funding: BOF - scientific equipment program
- Development and validation of a novel platform for fast and easy diagnosis of von Willebrand diseaseFrom1 Jan 2021 → 31 Dec 2022Funding: IOF - technology validation in lab
- Towards improved thrombolysis in ischemic stroke exploring novel therapeutic targetsFrom15 Sep 2020 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Development of a microfluidic platform for self-governing selection of individual B-cells using bioresponsive hydrogels: a source of fully human therapeutic antibodiesFrom20 Aug 2020 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Thrombosis in COVID-19:dysregulation of the tromboinflammatory VWF/ADAMTS13 axis?From1 Apr 2020 → 31 Mar 2021Funding: IOF - technology validation in lab
Publications
1 - 10 of 141
- Pretreatment with a dual antiplatelet and anticoagulant (APAC) reduces ischemia-reperfusion injury in a mouse model of temporary middle cerebral artery occlusion-implications for neurovascular procedures(2024)
Authors: Simon De Meyer
- White blood cell subtypes and neutrophil extracellular traps content as biomarkers for stroke etiology in acute ischemic stroke clots retrieved by mechanical thrombectomy(2024)
Authors: Simon De Meyer
Pages: 1 - 8 - GENE THERAPY FOR VON WILLEBRAND DISEASE(2023)
Authors: Sarah Vandelanotte, Claudia Tersteeg, Simon De Meyer
Pages: 326 - 330 - Measuring ADAMTS-13 activity to diagnose thrombotic thrombocytopenic purpura: a novel, fast fiber-optic surface plasmon resonance immunoassay(2023)
Authors: Quintijn Bonnez, Peter Verhamme, Claudia Tersteeg, Simon De Meyer, Jeroen Lammertyn, Karen Vanhoorelbeke
- Mechanical thrombectomy for acute ischemic stroke revealing a cardiac myxoma: histological and immunohistochemical study to determine myxomatous emboli(2023)
Authors: Simon De Meyer
Pages: 1201 - 1203 - Small-Molecule Cyclophilin Inhibitors Potently Reduce Platelet Procoagulant Activity(2023)
Authors: Simon De Meyer, Karen Vanhoorelbeke, Claudia Tersteeg
- In vitro characterization of a novel Arg102 mutation in the ADAMTS13 metalloprotease domain(2023)
Authors: Claudia Tersteeg, Simon De Meyer, Karen Vanhoorelbeke
Pages: 682 - 690 - ADAMTS13 conformation and immunoprofiles in Japanese patients with immune-mediated thrombotic thrombocytopenic purpura(2023)
Authors: Kazuya Sakai, Laure De Waele, Claudia Tersteeg, Simon De Meyer, Karen Vanhoorelbeke
Pages: 131 - 140 - ADAMTS13 inhibition to treat acquired von Willebrand syndrome during mechanical circulatory support device implantation(2022)
Authors: Shannen Deconinck, Christophe Vandenbriele, Bart Meyns, Claudia Tersteeg, Steven Jacobs, Simon De Meyer, Karen Vanhoorelbeke
Pages: 2797 - 2809 - Embotrap Extraction & Clot Evaluation & Lesion Evaluation for NeuroThrombectomy (EXCELLENT) Registry design and methods(2022)
Authors: Simon De Meyer
Pages: 783 - 787
Patents
1 - 5 of 5
- Dual targeting of tafi and pai-1 (Inventor)
- Dual targeting of tafi and pai-1 (Inventor)
- Compositions comprising adamts13 for use in methods for the recanalization of occluded blood vessels in an infarction (Inventor)
- Compositions comprising adamts13 for use in methods for the recanalization of occluded blood vessels in an infarction (Inventor)
- Dual targeting of tafi and pai-1 (Inventor)